Champions of patient centricity express a need for evidence of the value of involving patients and patient-centric clinical development practices to help them drive adoption and organizational change.
This dossier outlines emerging evidence of benefits/ROI of patient involvement in the trial development process from recent literature and provides illustrative case studies from PRA’s Center for Rare Diseases.
Explore related content and topics
Blog
How to Overcome Barriers in Rare Disease Drug Development
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam,…
Read Story
Blog
PRA Talks COVID-19 Impact on Rare Disease Clinical Trials with Patient Advocates
PRA’s Center for Rare Diseases understands that clinical trials are both a source of hope and care for people affected by a rare disease. The impact…
Read Story
Blog
Rare Disease Registries: How to Become Part of the Cure
Read Story
View all related content and resources for Rare Disease
Explore Insights